Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Research & Development (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Research & Development readings, the most recent being $46.1 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 11.75% to $46.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $193.1 million, a 2.9% decrease, with the full-year FY2025 number at $193.1 million, down 2.9% from a year prior.
  • Research & Development hit $46.1 million in Q4 2025 for Tandem Diabetes Care, down from $48.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $52.2 million in Q4 2024 to a low of $18.0 million in Q1 2021.
  • Median Research & Development over the past 5 years was $42.4 million (2023), compared with a mean of $39.6 million.
  • Biggest five-year swings in Research & Development: soared 84.62% in 2022 and later decreased 11.75% in 2025.
  • Tandem Diabetes Care's Research & Development stood at $29.5 million in 2021, then increased by 20.66% to $35.6 million in 2022, then grew by 19.72% to $42.6 million in 2023, then increased by 22.52% to $52.2 million in 2024, then decreased by 11.75% to $46.1 million in 2025.
  • The last three reported values for Research & Development were $46.1 million (Q4 2025), $48.7 million (Q3 2025), and $48.1 million (Q2 2025) per Business Quant data.